SONM on XNAS, Technology, DNA X, Inc., job postings
Measures activity, not value. Not investment advice.
Shares fell 79% in a year while the company lost $8.5M and filed a late-filing notice.
BadCash of just $900K on the balance sheet
WatchTwo director or officer changes filed in the last 90 days
Written by AI from the data on this page, 22 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Jun 2026
DNA X Inc is engaged in providing crypto trading services through its online platform, enabling users to buy, sell, and exchange cryptocurrencies, as well as execute automated trading strategies between currency pairs. The company generates revenue from commissions and fees on trading activity.
Revenue and net income per quarter. Quarter to 30 Jun 2026: net loss $1.2M.
31 Dec 2021RevenueNet incomeNet losstallest bar $27.6M30 Jun 2026
See the numbers
Quarter to
Revenue
Net income
30 Jun 2026
–
-$1.2M
31 Mar 2026
–
$6.3M
31 Dec 2025
–
-$8.9M
30 Sep 2025
$16.2M
-$4.8M
30 Jun 2025
$11.2M
-$7.5M
31 Mar 2025
$16.7M
$458K
31 Dec 2024
$15.0M
-$21.6M
30 Sep 2024
$15.0M
-$2.5M
30 Jun 2024
$11.5M
-$6.6M
31 Mar 2024
$16.8M
-$2.9M
31 Dec 2023
$13.4M
-$1.4M
30 Sep 2023
$27.6M
$527K
30 Jun 2023
$26.8M
$509K
31 Mar 2023
$25.8M
$227K
31 Dec 2022
$24.1M
-$1.0M
30 Sep 2022
$20.5M
-$1.6M
30 Jun 2022
$12.0M
-$4.2M
31 Mar 2022
$13.3M
-$7.2M
31 Dec 2021
$15.9M
-$11.7M
Fundamentals, 12 months to 30 Jun 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
–
$57.9M
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
–
+21%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
-$8.5M
-$31.1M
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
–
–
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
–
22.9%
35.2%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
–
-46.3%
5.0%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
–
-53.8%
5.3%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
–
10.9%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
–
–
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$900K
$2.0M
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
–
$2.9M
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
–
$910K
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
–
0.37
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
–
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
loss
29.4
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
–
1.8
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
–
3.1
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
–
2.3
Latest = 12 months to 30 Jun 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
6.3%
93K shares held by 13F filers (30 Sep 2026) of 1.5M outstanding (18 Aug 2026)
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
0.7%
9,830 shares sold short (30 Oct 2026) of 1.5M outstanding (18 Aug 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
1.0
9,830 shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
-9.1%
11K shares sold short in the report before, 9,830 on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
18%
18% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 44%
News iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
9
9 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
–
9 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.
Price $1.51 on 20 Nov 2026, -79% over 12 months (12-month range $1.51 to $7.38)
Sharp change
8-K and other filings
Insider net buying (open market). Insiders bought a net $0 in the last 12 months (the 12 months before: -$1.4M).Revenue per quarter. Revenue $16.2M in the latest quarter, +7.9% on a year earlier.Capital spending per quarter. Capital spending $8K in the latest quarter, -33% on a year earlier.Institutional holders (13F filers). 9 13F filers reported holding it in the latest 13F quarter, -36% on a year earlier.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, lobbying spend, workers in warn layoff notices.
Quarter ended 31 Dec 2021: $15.9M, +0.6% on a year earlier; public on 22 Mar 2022
Quarter ended 31 Mar 2022: $13.3M, +8.3% on a year earlier; public on 11 May 2022
Quarter ended 30 Jun 2022: $12.0M, 0% on a year earlier; public on 13 Aug 2022
Quarter ended 30 Sep 2022: $20.5M, +42% on a year earlier; public on 15 Nov 2022
Quarter ended 31 Dec 2022: $24.1M, +51% on a year earlier; public on 21 Mar 2023
Quarter ended 31 Mar 2023: $25.8M, +95% on a year earlier; public on 9 May 2023
Quarter ended 30 Jun 2023: $26.8M, +124% on a year earlier; public on 15 Aug 2023
Quarter ended 30 Sep 2023: $27.6M, +34% on a year earlier; public on 15 Nov 2023
Quarter ended 31 Dec 2023: $13.4M, -44% on a year earlier; public on 28 Mar 2024
Quarter ended 31 Mar 2024: $16.8M, -35% on a year earlier; public on 15 May 2024
Quarter ended 30 Jun 2024: $11.5M, -57% on a year earlier; public on 10 Aug 2024
Quarter ended 30 Sep 2024: $15.0M, -46% on a year earlier; public on 14 Nov 2024
Quarter ended 31 Dec 2024: $15.0M, +12% on a year earlier; public on 1 Apr 2025
Quarter ended 31 Mar 2025: $16.7M, -0.3% on a year earlier; public on 13 May 2025
Quarter ended 30 Jun 2025: $11.2M, -2.8% on a year earlier; public on 9 Aug 2025
Quarter ended 30 Sep 2025: $16.2M, +7.9% on a year earlier; public on 1 Nov 2025
Capital spending per quarter
Quarter ended 31 Dec 2021: $26K; public on 22 Mar 2022
Quarter ended 31 Mar 2022: $3K; public on 11 May 2022
Quarter ended 30 Jun 2022: $3K; public on 13 Aug 2022
Quarter ended 31 Dec 2022: $2K, -92% on a year earlier; public on 21 Mar 2023
Quarter ended 30 Sep 2023: $1K; public on 15 Nov 2023
Quarter ended 31 Dec 2023: $12K, +500% on a year earlier; public on 28 Mar 2024
Quarter ended 31 Mar 2024: $30K; public on 15 May 2024
Quarter ended 30 Jun 2024: $39K; public on 10 Aug 2024
Quarter ended 30 Sep 2024: $137K, +13600% on a year earlier; public on 14 Nov 2024
Quarter ended 31 Dec 2024: $8K, -33% on a year earlier; public on 1 Apr 2025
Institutional holders (13F filers)
31 Dec 2021 report: 15; public on 14 Feb 2022
31 Mar 2022 report: 13; public on 16 May 2022
30 Jun 2022 report: 12; public on 15 Aug 2022
30 Sep 2022 report: 17; public on 14 Nov 2022
31 Dec 2022 report: 13; public on 14 Feb 2023
31 Mar 2023 report: 13; public on 15 May 2023
30 Jun 2023 report: 12; public on 14 Aug 2023
30 Sep 2023 report: 16; public on 14 Nov 2023
31 Dec 2023 report: 18; public on 14 Feb 2024
31 Mar 2024 report: 20; public on 15 May 2024
30 Jun 2024 report: 17; public on 14 Aug 2024
30 Sep 2024 report: 9; public on 14 Nov 2024
31 Dec 2024 report: 10; public on 14 Feb 2025
31 Mar 2025 report: 11; public on 15 May 2025
30 Jun 2025 report: 16; public on 14 Aug 2025
30 Sep 2025 report: 14; public on 14 Nov 2025
31 Dec 2025 report: 8; public on 17 Feb 2026
31 Mar 2026 report: 9; public on 15 May 2026
30 Jun 2026 report: 9; public on 14 Aug 2026
30 Sep 2026 report: 9; public on 16 Nov 2026
What is unusual now
Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market selling (USD, Form 4) at $1.3M (30 Jun 2025), 310× its normal reading; higher than 96% of its own history.
Two or more unrelated kinds of records unusual within 30 days
30 Jun 2020confirmed
Confirmed across sources Insiders and Short interest and volume
DNA X(SONM): had 4 insiders buy $246K of its shares on the open market within 30 days (4 filings), while it had 671K shares sold short in the 15 Jun 2020 report, 4.0× the same report last year. Two unrelated kinds of activity within 18 days.
Insiders: Clustered insider buying, became public on 12 Jun 2020
Short interest and volume: Short interest spike, became public on 25 Jun 2020
The 15 Jun 2020 report against the 24 reports before it.
this reportearliernormal: 244KSee the evidence (2 changes)
Insiders: Clustered insider buying became public on 12 Jun 2020
DNA X had 4 insiders buy $246K of its shares on the open market within 30 days (4 filings).
Independent buyers
4
Purchase filings (Form 4, code P)
4
Total bought
$246K
Window
13 May 2020 to 12 Jun 2020
Hochschild Maurice (director) bought 15,000 shares of SONM ($11,250)dated 11 Jun 2020, public 12 Jun 2020
Howe Alan B (director) bought 13,333 shares of SONM ($10,000)dated 11 Jun 2020, public 12 Jun 2020
TIRVA ROBERT L. (Chief Financial Officer) bought 100,000 shares of SONM ($75,000)dated 11 Jun 2020, public 12 Jun 2020
Wilkinson Thomas Wiley (Chief Executive Officer) bought 200,000 shares of SONM ($150,000)dated 11 Jun 2020, public 12 Jun 2020
Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.
Short interest and volume: Short interest spike became public on 25 Jun 2020
DNA X had 671K shares sold short in the 15 Jun 2020 report, 4.0× the same report last year.
This period
671K (the 15 Jun 2020 report)
Normal report (median of 24 earlier)
244K
Typical spread (median absolute deviation)
81K
How far from its usual level
+3.5
Same report last year
166K
History used
397 days
the 15 Jun 2020 report24 earlier reportsnormal: 244K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
Timeline
Changes and notable records, by the date each became public
had 736K shares sold short in the 15 Oct 2025 report, 11× the same report last year.
Same report last year: 68K; its normal report is 68K.
See the evidence
This period
736K (the 15 Oct 2025 report)
Normal report (median of 24 earlier)
68K
Typical spread (median absolute deviation)
30K
How far from its usual level
+13.4
Same report last year
68K
History used
2,345 days
the 15 Oct 2025 report24 earlier reportsnormal: 68K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.1M shares sold short in the 30 Sep 2025 report, 16× the same report last year.
Same report last year: 72K; its normal report is 68K.
See the evidence
This period
1.1M (the 30 Sep 2025 report)
Normal report (median of 24 earlier)
68K
Typical spread (median absolute deviation)
28K
How far from its usual level
+21.2
Same report last year
72K
History used
2,330 days
the 30 Sep 2025 report24 earlier reportsnormal: 68K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 510K shares sold short in the 15 Jul 2024 report, 2.0× the same report last year.
Same report last year: 261K; its normal report is 139K.
See the evidence
This period
510K (the 15 Jul 2024 report)
Normal report (median of 24 earlier)
139K
Typical spread (median absolute deviation)
67K
How far from its usual level
+3.8
Same report last year
261K
History used
1,888 days
the 15 Jul 2024 report24 earlier reportsnormal: 139K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 629K shares sold short in the 28 Jun 2024 report, 2.4× the same report last year.
Same report last year: 258K; its normal report is 139K.
See the evidence
This period
629K (the 28 Jun 2024 report)
Normal report (median of 24 earlier)
139K
Typical spread (median absolute deviation)
67K
How far from its usual level
+5.0
Same report last year
258K
History used
1,871 days
the 28 Jun 2024 report24 earlier reportsnormal: 139K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Showing the newest 40 of 106 entries; narrow the window or the kind of data to see older ones.
Not listed: 131 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0001178697
Ticker
SONM
Domain
dnax.us
Hq location
CA|SAN DIEGO|92121 (1 unverified)
Name
DNA X, Inc., Sonim Communications (India) Private Limited, Sonim Technologies Germany GmbH, Sonim Technologies (Hong Kong) Limited and 5 more
Wikidata
Q1225892
SEC Form 13F institutional holdings270 data points30 Jun 2019 to 30 Sep 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)170 records7 Oct 2016 to 17 Nov 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)580 data points31 Dec 2017 to 18 Aug 2026
SEC Form 4 insider transactions42 records, 108 data points23 May 2019 to 30 Jun 2025
FINRA short interest (twice monthly)536 data points15 May 2019 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)3790 data points10 May 2019 to 20 Nov 2026